🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will determine changes in: 1) the immune activity, characterized...
Status
Unknown
Location
Tanner Center for MS
Start Date
2013-08
Trial ID
NCT01906684
Treatments Being Tested
This pilot study is designed as a prospective cohort study to determine whe...
Status
Completed
Location
The MS Center at the Neurology Center in Southern California
Start Date
2013-04
Trial ID
NCT01888354
Treatments Being Tested
Uveitis represents a heterogeneous group of diseases that results from ocul...
Status
Completed
Location
Tampa Bay Uveitis Center
Start Date
2016-06-30
Trial ID
NCT02764697
Treatments Being Tested
This study will assess the safety and efficacy of H.P. Acthar gel for treat...
Status
Completed
Location
Cleveland Clinic
Start Date
2015-06-15
Trial ID
NCT02245841
Treatments Being Tested
About 213 people with ALS will participate in this study. There will be loc...
Status
Terminated
Location
Neuromuscular Research Center
Start Date
2017-06-22
Trial ID
NCT03068754
The purpose of this study is to find out if Acthar Gel is safe and effectiv...
Status
Completed
Location
UAB Lung Health Center
Start Date
2018-02-21
Trial ID
NCT03320070
Treatments Being Tested
This is a pilot study to measure levels of albumin and inflammatory cytokin...
Status
Completed
Location
Wilmer Eye Institute, Johns Hopkins Hospital
Start Date
2019-08-19
Trial ID
NCT03727776
Treatments Being Tested
This Phase 4 study is being performed to examine the effects of Acthar for ...
Status
Completed
Location
Mallinckrodt Investigational Site
Start Date
2013-01
Trial ID
NCT01753401
Treatments Being Tested
This is a 2-part study to examine the effect of Acthar Gel in adult partici...
Status
Completed
Location
East Bay Rheumatology Medical Group
Start Date
2016-11-07
Trial ID
NCT02919761
Treatments Being Tested
Systemic lupus erythematosus is a serious and potentially life-threatening ...
Status
Completed
Location
Justus J. Fiechtner
Start Date
2012-10
Trial ID
NCT01769937
Treatments Being Tested